Product NDC: | 0121-4776 |
Proprietary Name: | Megestrol Acetate |
Non Proprietary Name: | MEGESTROL ACETATE |
Active Ingredient(s): | 40 mg/mL & nbsp; MEGESTROL ACETATE |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0121-4776 |
Labeler Name: | Pharmaceutical Associates, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076721 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060707 |
Package NDC: | 0121-4776-20 |
Package Description: | 4 TRAY in 1 CASE (0121-4776-20) > 10 CUP, UNIT-DOSE in 1 TRAY > 20 mL in 1 CUP, UNIT-DOSE |
NDC Code | 0121-4776-20 |
Proprietary Name | Megestrol Acetate |
Package Description | 4 TRAY in 1 CASE (0121-4776-20) > 10 CUP, UNIT-DOSE in 1 TRAY > 20 mL in 1 CUP, UNIT-DOSE |
Product NDC | 0121-4776 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MEGESTROL ACETATE |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20060707 |
Marketing Category Name | ANDA |
Labeler Name | Pharmaceutical Associates, Inc. |
Substance Name | MEGESTROL ACETATE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |